Early n = 245 | Late n = 244 | P-value | |
---|---|---|---|
Rejected by attending physician | 144 (59%) | 140 (57%) | 0.7540 |
Sex, male | 170 (69%; 63 to 75) | 159 (65%; 59 to 71) | 0.3196 |
Age | 64 (18 to 89) | 65.5 (19 to 88) | 0.7814 |
SAPS 2 | 38 (3 to 78) | 37.5 (10 to 85) | 0.6272 |
Probability of death (SAPS 2) | 0.21 (0.00 to 0.91) | 0.21 (0.01 to 0.95) | 0.6315 |
SAPS 3 | 62 (31 to 114) | 61 (29 to 105) | 0.8088 |
Probability of death (SAPS 3) | 0.40 (0.02 to 0.96) | 0.38 (0.02 to 0.93) | 0.8108 |
APACHE II | 20 (5 to 40) | 19 (4 to 38) | 0.2353 |
ISS, n | 29 (9 to 66) [32] | 30 (25 to 59) [20] | 0.6165 |
SOFA admission | 9 (1 to 19) | 9 (1 to 20) | 0.8665 |
SOFA decision | 6 (1 to 17) | 6 (0 to 15) | 0.6943 |
Difference between SOFA | 2 (-7 ; 14) | 3 (-5 ; 11) | 0.6100 |
Elective surgery | 69 (28%; 22 to 34) | 61(25%; 20 to 31) | 0.4285 |
Trauma | 32 (13%; 9 to 18) | 20 (8%; 5 to 12) | 0.0810 |
Emergency surgery | 43 (18%; 13 to 24) | 57 (23%; 18 to 29) | 0.1113 |
Medical condition | 101 (41%; 35 to 48) | 106 (44%; 38 to 51) | 0.6196 |
Inhaled nitric oxide | 20 (8%; 6 to 20) | 21 (9%; 6 to 21) | 0.8596 |
Prone decubitus | 17 (7%; 4 to 17) | 25 (10%; 7 to 21) | 0.1919 |
Swan-Ganz catheter | 37 (15%; 10 to 26) | 32 (13%; 10 to 25) | 0.5159 |
Renal replacement techniques | 35 (14%; 4 to 17) | 37 (15%; 11 to 26) | 0.7841 |
Vasoactive drugs | 204 (83%; 74 to 90) | 213 (87%; 84 to 96) | 0.2086 |
Parenteral nutrition | 70 (29%; 17 to 35) | 76 (31%; 16 to 34) | 0.5337 |
Intracranial pressure monitoring | 35 (14%; 10 to 26) | 19 (8%; 3 to 15) | 0.0219 |
Circulatory assist | 15 (6%; 2 to 12) | 15 (6%; 2 to 12) | 0.9908 |
Main reason for ventilatory support | |||
Acute respiratory insufficiency | 167 (68%; 62 to 74) | 176 (72%; 66 to 78) | 0.3703 |
Neuromuscular illness | 5 (2%; 0.7 to 5) | 4 (2%; 0.7 to 5) | 0.7365 |
Coma (Glasgow coma score <10) | 60 (24%; 19 to 30) | 46 (19%, 14 to 24) | 0.1241 |
Decompensated COPD | 11 (5%; 3 to 8) | 14 (6%; 3 to 10) | 0.5379 |
Acute asthma attack | 1 | 1 | |
Other respiratory disease | 1 | 3 |